Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)
Titel:
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)
Auteur:
Kim, Ji-Yeon Lee, Eunjin Park, Kyunghee Im, Seock-Ah Sohn, Joohyuk Lee, Keun Seok Chae, Yee Soo Kim, Jee Hyun Kim, Tae-Yong Jung, Kyung Hae Park, Yeon Hee